缺血性心肌病和扩张性心肌病之间的T细胞相关血清标志物的差异
Yuli Huang1, Lin Xuan1, Qiong Xu1
1Department of Cardiovascular Medicine, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Journal of thoracic disease
|August 15, 2024
概括
研究人员确定了四种与T细胞相关的血清标记物:化学因子联接体21 (CCL21),白内素-1β (IL-1β),淋巴细胞激活基因3 (LAG3) 和血管细胞粘附分子-1 (VCAM-1). 这些标记可以帮助区分缺血性心肌病 (ICM) 和扩张性心肌病 (DCM).
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 缺血性心肌病 (ICM) 和扩张性心肌病 (DCM) 具有共同的临床症状,但具有不同的潜在原因.
- 区分ICM和DCM对于适当的治疗和患者的治疗结果至关重要.
研究的目的:
- 确定能够区分ICM和DCM的T细胞相关血清标记物.
- 使用已知的方法验证这些标记物的诊断潜力.
主要方法:
- 转录组测序确定了患者群体之间的差异表达基因 (DEG).
- 基因本体学和KEGG丰富分析阐明了功能途径.
- 蛋白质与蛋白质相互作用网络突出显示了关键的T细胞相关基因.
- 与酶相关的免疫吸收试验 (ELISA) 测量了血清蛋白质水平.
- 接收器操作特征 (ROC) 曲线分析评估了诊断准确性.
主要成果:
- 确定了与T细胞激活和分化相关的DEG和丰富功能.
- 免疫细胞评分揭示了ICM和非失败的捐赠者/DCM之间的特定T细胞种群的显著差异.
- 在ICM患者中,四种分泌蛋白CCL21,IL-1β,LAG3和VCAM-1显著上调.
- 在ICM患者中,与DCM患者相比,CCL21,IL-1β,LAG3和VCAM-1的血清水平显著更高,诊断AUC值高.
结论:
- CCL21,IL-1β,LAG3和VCAM-1被确定为潜在的血清生物标志物.
- 这些标志物在区分ICM和DCM方面表现出显著的有效性.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
119
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69


